EGFR and non-small cell lung carcinoma: We previously showed that 11C-erlotinib could be used to identify tumours overexpressing the EGFR in animal models (Memon et al, 2009), and we have presented a case report showing accumulation of 11C-erlotinib in brain metastasis of a patient with NSCLC (Weber et al, 2011).